Project Management and Portfolio Review

“Competition is only likely to intensify and by using Biocomm² to plan and implement robust portfolio and project management, Alchemia has put itself in a strong position to partner with global pharmaceutical companies.” -Pete Smith, CEO Alchemia Ltd

Portfolio management decisions and associated capital allocation are make or break decisions for biotechnology and biomedical companies. Quality project management systems which offer “Go or No-Go” decisions at the earliest possible points are an absolute necessity when funding is tight.

Biocomm² will provide biotech companies with our project management and portfolio review program. Our experienced principals work with biotech executives to build individually tailored strategy for companies’ projects and decision-making systems.

In order to facilitate this services and other operations, one of our principals may have an interim management role for our clients. With highly valued experience, insight and strategic and commercial expertise, this can add great value during difficult scenarios, startup or rapid growth situations.